Onconetix, Inc.
ONCO
$0.53
$0.012.79%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -57.36% | -25.36% | -84.89% | -85.49% | 1,117.09% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -57.36% | -25.36% | -84.89% | -85.49% | 1,117.09% |
| Cost of Revenue | 7.50% | -88.45% | -94.04% | -89.09% | -95.61% |
| Gross Profit | -62.47% | 155.12% | -29.99% | -75.77% | 158.55% |
| SG&A Expenses | -42.83% | -11.38% | -31.41% | -55.19% | -59.08% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -40.95% | -22.27% | -48.69% | -59.17% | -63.83% |
| Operating Income | 35.02% | 21.80% | 36.63% | 54.04% | 73.21% |
| Income Before Tax | 118.68% | -126.16% | 83.36% | 23.97% | -35.74% |
| Income Tax Expenses | 100.05% | -- | -- | -- | -7,185.71% |
| Earnings from Continuing Operations | 119.26% | -129.50% | 83.42% | 23.14% | -31.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 119.26% | -129.50% | 83.42% | 23.14% | -31.71% |
| EBIT | 35.02% | 21.80% | 36.63% | 54.04% | 73.21% |
| EBITDA | 31.02% | 15.39% | 30.17% | 51.38% | 74.70% |
| EPS Basic | 101.23% | 97.49% | -- | -- | -- |
| Normalized Basic EPS | 150.00% | 99.76% | -- | -- | -- |
| EPS Diluted | 101.23% | 97.49% | -- | -- | -- |
| Normalized Diluted EPS | 150.00% | 99.76% | -- | -- | -- |
| Average Basic Shares Outstanding | 1,457.60% | 9,026.62% | -- | -- | -- |
| Average Diluted Shares Outstanding | 1,457.60% | 9,026.62% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |